ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Vascular disease"

  • 2017 American Transplant Congress

    HLA, ANA, and ANCA Negative Vasculitis in Lung Transplantation Due to Overexpression of α1 Collagen V.

    E. Daoud,1 Y. Butt,1 F. Torres,2 T. Jose.1

    1Pathology, University of Texas Southwestern Medical Center, Dallas, TX; 2Lung Transplant Program, University of Texas Southwestern Medical Center, Dallas, TX

    The mechanism of fibrosing vasculopathy in lung allograft is poorly understood. A 58 year old man received a bilateral lung transplant for interstitial lung disease.…
  • 2017 American Transplant Congress

    Transcatheter Relief of Symptomatic Hepatic Venous Outflow Obstruction Following Pediatric Liver Transplantation.

    B. Goldstein, G. Tiao, M. Alonso, N. Johnson, J. Heubi, K. Averin, J. Bucuvalas.

    Cincinnati Children's Hospital, Cincinnati, OH

    Background: Technical-variant allograft (TVA) pediatric liver transplantation (LT) is associated with vascular complications. Early recognition and treatment of hepatic venous outflow obstruction (HVOO) may be…
  • 2017 American Transplant Congress

    Association Between Matrix-gla Protein Levels and Aortic Stiffness in Kidney Transplantation.

    M. Dinic,1 N. Maillard,1 P. Delanaye,2 J.-M. Krzesinski,2 A.-M. Saint-Remy,2 E. Cavalier,3 C. Mariat.1

    1Nephrology, Dialysis and Renal Transplantation, CHU Nord, Saint Etienne, France; 2Nephrology and Dialysis, University of Liège, CHU Sart Tilman, Liège, Belgium; 3Clinical Chemistry, University of Liège, CHU Sart Tilman, Liège, Belgium

    INTRODUCTIONAortic stiffness due to vascular calcifications is commonly observed among kidney transplant recipients and is considered as a predictive factor of poor events such as…
  • 2017 American Transplant Congress

    Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

    N. Lam,1 M. Tonelli,2 K. Lentine,3 B. Hemmelgarn,2 F. Ye,1 A. Bello,1 S. Klarenbach.1

    1University of Alberta, Edmonton, Canada; 2University of Calgary, Calgary, Canada; 3Saint Louis University, St. Louis

    The risk of mortality and graft loss is higher in kidney transplant recipients with reduced estimated glomerular filtration rate (eGFR) and heavier albuminuria. It is…
  • 2016 American Transplant Congress

    Pre-Transplant Cardiovascular Risk Factors Affect Kidney Allograft Survival: A Multi-Center Study in Korea.

    J. An,1,2 S. Ahn,3 E. Bae,2 E. Kang,2 H.-L. Kim,4 Y.-J. Kim,5 Y. Oh,1,2 C. Lim,1,2 Y. Kim,2 Y. Kim,6 J. Lee.1,2

    1Division of Nephrology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; 2Division of Nephrology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; 3Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Gangwon-do, Korea; 4Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; 5Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; 6Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.

    Background - Pre- or post-transplant cardiovascular (CV) risk factors affect the development of CV events even after successful kidney transplantation (KT). However, the impact of…
  • 2016 American Transplant Congress

    Outcomes of EVAR in Kidney Transplant Recipients: Results form a National Quality Initiative.

    I. Bostock,1 D. Zarkowsky,1 D. Stone,1 M. Eslami,2 M. Malas,3 P. Goodney.1

    1Vascular Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH; 2Vascular Surgery, Boston Medical Center, Boston, MA; 3School of Public Health, John Hopkins Medical School, Baltimore, MD.

    BACKGROUND:Contrast-induced nephropathy following endovascular aortic aneurysm repair (EVAR) in renal transplant patients can have devastating consequences. We describe outcomes within a national cohort of kidney…
  • 2016 American Transplant Congress

    Exosome-Like Vesicles Released in Association with Tissue Injury Trigger Anti-LG3 Production.

    M. Dieudé,1,2,3 J. Turgeon,1,3 B. Yang,1,2,3 L. Pomerleau,1,3 K. Hamelin,1,3 S. Lan,1,2,3 S. Qi,1,3 D. Gingras,1,3 W. Dhari,1 A. Rivard,1 M.-J. Hébert.1,2,3

    1Research Centre, Centre hospitalier de l'Université de Montréal, Montréal, Canada; 2Université de Montréal, Montréal, Canada; 3Canadian National Transplantation Research Program, Edmonton, Canada.

    Pre-transplant levels of autoantibodies to perlecan/LG3 predict poor allograft outcomes in renal transplant patients. We showed previously thatapoptotic exosome-like vesicles (ApoExo) enhance anti-LG3 production and…
  • 2016 American Transplant Congress

    Air Pollution – An Additional Risk Factor for Developing Cardiac Allograft Vasculopathy.

    C. Bara, D. Böthig, Y. Scheibner, D. Bobylev, B. Przybylek, A. Haverich.

    Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

    Purpose:Cardiac allograft vasculopathy (CAV) remains one of the primary causes of death in long-term follow-up after heart transplantation (HTx) and is the most limiting factor…
  • 2016 American Transplant Congress

    Higher Functional Capacity Prior to Kidney Transplant Confers Lower Risk of New Onset Diabetes After Transplantation.

    I. Qaqish, S. Behmen, R. Heilman, H. Khamash, J. Huskey, S. Nair, H. Chakkera.

    Mayo Clinic, Phoenix, AZ.

    Background: New onset diabetes after transplantation (NODAT) adversely impacts both allograft function and patient survival. We hypothesize that higher functional capacity prior to kidney transplant…
  • 2016 American Transplant Congress

    Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.

    M. Konerman,1 D. Fritze,2 R. Weinberg,3 E. Spengler,1 C. Sonnenday,2 P. Sharma.1

    1Hepatology, Univ of Michigan, Ann Arbor, MI; 2Transplantation Surgery, Univ of Michigan, Ann Arbor, MI; 3Cardiology, Univ of Michigan, Ann Arbor, MI.

    Purpose: Cardiovascular (CV) events remain a major source of morbidity and mortality following liver transplantation (LT). This review evaluates the incidence of and risk assessment…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences